Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1987 Jan;60(1):13–18.

Suppressor response in lepromatous leprosy patients: role of Leu 2a cells.

M del Carmen Sasiain, S de la Barrera, B Ruibal-Ares, J E Cardama, J C Gatti, M M de Bracco
PMCID: PMC1453357  PMID: 2950048

Abstract

The contribution of non-specific suppressor mechanisms to the overall immunoregulatory defect observed in lepromatous leprosy was evaluated. Con A-induced suppression was assayed using the standard two-stage test in 27 lepromatous leprosy patients, 19 of them during the quiescent stage (LL) and eight during erythema nodosum lepromatosum (ENL). Lymphocytes from normal individuals react in this assay, yielding higher suppression as the numbers of Con A-induced suppressor cells (Leu 2a+ cells) increase. In contrast, two patterns of response were observed in both LL and ENL patients: those giving lower suppression as the number of suppressor cells increased (LL-A and ENL-A) and those responding with the normal pattern (LL-B and ENL-B). The abnormal dose-response profile was not related to the disease stage, as both ENL and LL patients were included in groups with normal or atypical response. Reaction of the potential suppressor cells with anti-Leu 2a antibody abolished suppression in LL-B and normals, whereas Con A-induced suppression was unchanged or higher in ENL-A, ENL-B and LL-A, indicating that in these patients Leu 2a+ cells interfered with the generation of Con A-induced suppression. The contribution of spontaneous suppression was examined and it was shown that suppressor activity in the absence of Con A stimulus was higher in ENL (both ENL-A and ENL-B) and LL-A. Thus, it appears that the occurrence of high spontaneous suppressor activity, probably related to in vivo activation, is associated with a relative inability to generate de novo suppression after Con A stimulation in these patients.

Full text

PDF
13

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Artz R. P., Jacobson R. R., Bullock W. E. Decreased suppressor cell activity in disseminated granulomatous infections. Clin Exp Immunol. 1980 Aug;41(2):343–352. [PMC free article] [PubMed] [Google Scholar]
  2. Barnhill R. L., McDougall A. C. Thalidomide: use and possible mode of action in reactional lepromatous leprosy and in various other conditions. J Am Acad Dermatol. 1982 Sep;7(3):317–323. doi: 10.1016/s0190-9622(82)70118-5. [DOI] [PubMed] [Google Scholar]
  3. Bonney R. J., Humes J. L. Physiological and pharmacological regulation of prostaglandin and leukotriene production by macrophages. J Leukoc Biol. 1984 Jan;35(1):1–10. doi: 10.1002/jlb.35.1.1. [DOI] [PubMed] [Google Scholar]
  4. Bullock W. E. Leprosy: a model of immunological perturbation in chronic infection. J Infect Dis. 1978 Mar;137(3):341–354. doi: 10.1093/infdis/137.3.341. [DOI] [PubMed] [Google Scholar]
  5. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  6. Dierks R. E., Shepard C. C. Effect of phytohemagglutinin and various mycobacterial antigens on lymphocyte cultures from leprosy patients. Proc Soc Exp Biol Med. 1968 Feb;127(2):391–395. doi: 10.3181/00379727-127-32698. [DOI] [PubMed] [Google Scholar]
  7. Dwyer J. M., Johnson C. The regulation of T cell responses by spontaneously active suppressor cells. Clin Exp Immunol. 1982 Nov;50(2):406–415. [PMC free article] [PubMed] [Google Scholar]
  8. Engleman E. G., Benike C. J., Metzler C., Gatenby P. A., Evans R. L. Blocking of human T lymphocyte functions by anti-Leu-2 and anti-Leu-3 antibodies: differential inhibition of proliferation and suppression. J Immunol. 1983 Jun;130(6):2623–2628. [PubMed] [Google Scholar]
  9. Fauci A. S., Steinberg A. D., Haynes B. F., Whalen G. Immunoregulatory aberrations in systemic lupus erythematosus. J Immunol. 1978 Oct;121(4):1473–1479. [PubMed] [Google Scholar]
  10. Feighery C., Whelan C. A., Weir D. G., Greally J. F. In vitro studies of suppressor cell function in human peripheral blood mononuclear cells. Clin Exp Immunol. 1978 Jun;32(3):459–465. [PMC free article] [PubMed] [Google Scholar]
  11. Mehra V., Mason L. H., Fields J. P., Bloom B. R. Lepromin-induced suppressor cells in patients with leprosy. J Immunol. 1979 Oct;123(4):1813–1817. [PubMed] [Google Scholar]
  12. Moncada B., Baranda M. L., González-Amaro R., Urbina R., Loredo C. E. Thalidomide--effect on T cell subsets as a possible mechanism of action. Int J Lepr Other Mycobact Dis. 1985 Jun;53(2):201–205. [PubMed] [Google Scholar]
  13. Myrvang B., Godal T., Ridley D. S., Fröland S. S., Song Y. K. Immune responsiveness to Mycobacterium leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy. Clin Exp Immunol. 1973 Aug;14(4):541–553. [PMC free article] [PubMed] [Google Scholar]
  14. Ridley D. S., Jopling W. H. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis. 1966 Jul-Sep;34(3):255–273. [PubMed] [Google Scholar]
  15. Romain P. L., Schlossman S. F. Human T lymphocyte subsets. Functional heterogeneity and surface recognition structures. J Clin Invest. 1984 Nov;74(5):1559–1565. doi: 10.1172/JCI111571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Sakane T., Green I. Human suppressor T cells induced by concanavalin A: suppressor T cells belong to distinctive T cell subclasses. J Immunol. 1977 Sep;119(3):1169–1178. [PubMed] [Google Scholar]
  17. Sasiain M. C., Ruibal Ares B., Baliña L. M., Valdez R., Bachmann A. E. ConA-induced suppressor cells in lepromatous leprosy patients during and after erythema nodosum leprosum. Int J Lepr Other Mycobact Dis. 1983 Sep;51(3):321–327. [PubMed] [Google Scholar]
  18. Shou L., Schwartz S. A., Good R. A. Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors. J Exp Med. 1976 May 1;143(5):1100–1110. doi: 10.1084/jem.143.5.1100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Van Voorhis W. C., Kaplan G., Sarno E. N., Horwitz M. A., Steinman R. M., Levis W. R., Nogueira N., Hair L. S., Gattass C. R., Arrick B. A. The cutaneous infiltrates of leprosy: cellular characteristics and the predominant T-cell phenotypes. N Engl J Med. 1982 Dec 23;307(26):1593–1597. doi: 10.1056/NEJM198212233072601. [DOI] [PubMed] [Google Scholar]
  20. Wallach D., Cottenot F., Bach M. A. Imbalances in T cell subpopulations in lepromatous leprosy. Int J Lepr Other Mycobact Dis. 1982 Sep;50(3):282–290. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES